Rheumatology International

Editorial
pp. 997-997(1)
Author: Lemmel, Ernst-Martin

Fibromyalgia: a rheumatologic diagnosis?
pp. 999-1004(6)
Author: Endresen, Gerhard

The classification of fibromyalgia syndrome
pp. 1005-1010(6)
Authors: Müller, W.; Schneider, E.; Stratz, T.

Tender point count and total myalgic score in fibromyalgia: changes over a 28-day period
pp. 1011-1018(8)
Authors: McVeigh, J.; Finch, M.; Hurley, D.; Basford, J.; Sim, J.; Baxter, G.

The effects of multidisciplinary therapy on positron emission tomography of the brain in fibromyalgia: a pilot study
pp. 1019-1024(6)
Authors: Walitt, Brian; Roebuck-Spencer, Tresa; Esposito, Guiseppe; Atkins, Frances; Bleiberg, Joseph; Foster, Gregory; Weinstein, Arthur

5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome
pp. 1025-1030(6)
Authors: Seidel, Matthias; Weinreich, Gunter; Stratz, Thomas; Müller, Wolfgang

Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up
pp. 1031-1039(9)
Authors: Kötter, Ina; Neuscheler, Daniela; Günaydin, Ilhan; Wernet, Dorothee; Klein, Reinhild

Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years
pp. 1041-1048(8)
Authors: Wagner, E.; Ammer, K.; Kolarz, G.; Krajnc, I.; Palkonyai, E.; Scherak, O.; Schödl, C.; Singer, F.; Temesvari, P.; Wottawa, A.

Activin A suppresses interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells
pp. 1049-1055(7)
Authors: Chang, Deh-Ming; Liu, Shao-Hsiang; Lee, Herng-Sheng; Lai, Jenn-Hung; Chen, Chen-Hung

Transcription regulatory polymorphism −43T>C in the 5′-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy
pp. 1057-1061(5)
Authors: Chatzikyriakidou, Anthoula; Georgiou, Ioannis; Voulgari, Paraskevi; Papadopoulos, Christos; Tzavaras, Theodoros; Drosos, Alexandros

Cost effectiveness analysis of disease modifying antirheumatic drugs in rheumatoid arthritis
pp. 1063-1069(7)
Authors: Osiri, Manathip; Kamolratanakul, Pirom; Maetzel, Andreas; Tugwell, Peter

A pravastatin dose-escalation study in systemic lupus erythematosus
pp. 1071-1077(7)
Authors: Costenbader, Karen; Liang, Matthew; Chibnik, Lori; Aizer, Juliet; Kwon, Hannah; Gall, Victoria; Karlson, Elizabeth

Osteopoikilosis in a patient with rheumatoid arthritis complicated with dry eyes
pp. 1079-1082(4)
Author: Ureten, Kemal

Protracted familial mediterranean fever arthritis presenting as septic arthritis
pp. 1083-1085(3)
Authors: Usluer, Hale; Bircan, Zelal

Nephrotic syndrome as a clinical manifestation of systemic sclerosis
pp. 1087-1089(3)
Authors: Wielosz, Ewa; Majdan, Maria; Suszek, Dorota; Smarz-Widelska, Iwona; Korolczuk, Agnieszka; Korobowicz, Elżbieta

Seronegative Lyme arthritis
pp. 1091-1093(3)
Authors: Holl-Wieden, A.; Suerbaum, S.; Girschick, H.

Polymorphism of the prolactin extrapituitary promoter in psoriatic arthritis
pp. 1095-1096(2)
Authors: Štolfa, Jiří; Fojtíková, Markéta; Čejková, Pavlína; Černá, Marie; Šedová, Liliana; Dostál, Ctibor

The development of pneumomediastinum after pulmonary function testing in a patient with systemic sclerosis
pp. 1097-1098(2)
Authors: Jun, Jae-Bum; Song, Soon-Young